氨溴索联合干扰素γ雾化吸入治疗慢性支气管炎急性发作期的效果分析

The Analysis of Ambroxol Joint Interferon γ Aerosol Inhalation Treatment Chronic Bronchitis with Acute Exacerbation Effects

目的观察氨溴索联合干扰素γ雾化吸入治疗慢性支气管炎急性发作期的效果。方法将我院100例慢性支气管炎急性发作期患者随机分为治疗组及对照组，对照纽患者使用氨溴索注射液，治疗组患者在对照组的基础上加用干扰素γ雾化吸入。结果经过治疗，治疗组总有效率为920％，显著高于对照组的740％，差异有统计学意义（P〈0．05）；治疗组患者发热消失、咳嗽消失、湿哆音消失、痰液正常时间均显著少于对照组，差异有统计学意义（P〈0．05）。结论氨溴索联合干扰素γ雾化吸入治疗慢性支气管炎急性发作期效果明显，无明显不良反应，适合临床上广泛应用。

Objective Observed joint interferon γ aerosol inhalation treatment chronic bronchitis with acute exacerbation effects. Methods 100 cases of acute exacerbation of chronic bronchitis patients were randomly divided into treatment and control groups in our hospital, The control group patients were used ambroxol injection, the treatment gronp patients were plus IFN-γ on the basis of control group. Results After treatment, the treatment group＇s total effective rate was 92.0%, was significantly higher than control group＇s 74.0%, the difference was statistically significant （P 〈0.05）; treatment group patient＇s disappearance of fever, cough disappeared, moist rales disappeared, sputum normal timewere significantly less than the control group＇s, the difference was statistically significant （P 〈0.05）. Conclusion Ambroxol joint interferon 7 aerosol inhalation treatment chronic bronchitis with acute exacerbation effect is obvious, no significant adverse reactions, suitable for the widely used clinically.